1. Home
  2. FMY vs VNRX Comparison

FMY vs VNRX Comparison

Compare FMY & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FMY
  • VNRX
  • Stock Information
  • Founded
  • FMY 2005
  • VNRX N/A
  • Country
  • FMY United States
  • VNRX United States
  • Employees
  • FMY N/A
  • VNRX N/A
  • Industry
  • FMY Finance/Investors Services
  • VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • FMY Finance
  • VNRX Health Care
  • Exchange
  • FMY Nasdaq
  • VNRX Nasdaq
  • Market Cap
  • FMY 51.1M
  • VNRX 58.6M
  • IPO Year
  • FMY N/A
  • VNRX N/A
  • Fundamental
  • Price
  • FMY $12.19
  • VNRX $0.56
  • Analyst Decision
  • FMY
  • VNRX Strong Buy
  • Analyst Count
  • FMY 0
  • VNRX 4
  • Target Price
  • FMY N/A
  • VNRX $4.17
  • AVG Volume (30 Days)
  • FMY 10.1K
  • VNRX 133.8K
  • Earning Date
  • FMY 01-01-0001
  • VNRX 05-12-2025
  • Dividend Yield
  • FMY 6.98%
  • VNRX N/A
  • EPS Growth
  • FMY N/A
  • VNRX N/A
  • EPS
  • FMY N/A
  • VNRX N/A
  • Revenue
  • FMY N/A
  • VNRX $1,233,511.00
  • Revenue This Year
  • FMY N/A
  • VNRX $812.84
  • Revenue Next Year
  • FMY N/A
  • VNRX $162.93
  • P/E Ratio
  • FMY N/A
  • VNRX N/A
  • Revenue Growth
  • FMY N/A
  • VNRX 59.10
  • 52 Week Low
  • FMY $10.71
  • VNRX $0.43
  • 52 Week High
  • FMY $12.17
  • VNRX $1.02
  • Technical
  • Relative Strength Index (RSI)
  • FMY 55.97
  • VNRX 48.98
  • Support Level
  • FMY $12.12
  • VNRX $0.51
  • Resistance Level
  • FMY $12.22
  • VNRX $0.61
  • Average True Range (ATR)
  • FMY 0.07
  • VNRX 0.04
  • MACD
  • FMY 0.01
  • VNRX 0.00
  • Stochastic Oscillator
  • FMY 87.05
  • VNRX 48.40

About FMY First Trust Motgage Income Fund of Beneficial Interest

First Trust Mortgage Income Fund is a United States based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield and maturity.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: